Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12222347 | 0.76 | LMNA (0.43) | KDM4ELMNAMAPK1TSHRHIF1A | |
| SCHEMBL11273462 | 0.74 | LMNA (0.59) | KDM4ELMNAMAPK1MEN1KMT2A | |
| SCHEMBL23074660 | 0.72 | KCNH2 (0.54) | KDM4ELMNAMAPK1MEN1KMT2A | |
| SCHEMBL12212607 | 0.72 | KDM4E (0.59) | KDM4ELMNAMAPK1MEN1KMT2A | |
| SCHEMBL11438620 | 0.71 | CHRNB2 (0.58) | KDM4ELMNAMAPK1MEN1KMT2A | |
| SCHEMBL25873852 | 0.69 | CA1 (0.45) | KDM4ELMNAMAPK1KMT2AL3MBTL1 | |
| SCHEMBL10838063 | 0.68 | HIF1A (0.51) | KDM4ELMNAMAPK1MEN1KMT2A | |
| SCHEMBL23074706 | 0.68 | KCNH2 (0.64) | KCNH2TSHRFDPSLTA4H | |
| SCHEMBL19212913 | 0.68 | USP2 (0.39) | KDM4E | |
| SCHEMBL12978498 | 0.68 | LMNA (0.45) | KDM4ELMNATSHRHIF1AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | BIO-RAD LABORATORIES, INC. | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | ABCG2, SLC7A1, MSR1 | KDM4E 3830/4885LMNA 1875/4885MAPK1 4821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.